Research ArticleOriginal Article
Open Access

Identification of effective diagnostic genes and immune cell infiltration characteristics in small cell lung cancer by integrating bioinformatics analysis and machine learning algorithms

Yinyi Chen, Kexin Han, Yanzhao Liu, Qunxia Wang, Yang Wu, Simei Chen, Jianlin Yu, Yi Luo and Liming Tan
Saudi Medical Journal August 2024, 45 (8) 771-782; DOI: https://doi.org/10.15537/smj.2024.45.8.20240170

References

  1. 1.↵
    1. Thai AA,
    2. Solomon BJ,
    3. Sequist LV,
    4. Gainor JF,
    5. Heist RS.
    Lung cancer. Lancet 2021; 398: 535-554.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Wu F,
    2. Wang L,
    3. Zhou C.
    Lung cancer in China: current and prospect. Curr Opin Oncol 2021; 33: 40-46.
    OpenUrlCrossRef
  3. 3.↵
    1. Nicholson AG,
    2. Tsao MS,
    3. Beasley MB,
    4. Borczuk AC,
    5. Brambilla E,
    6. Cooper WA, et al.
    The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol 2022; 17: 362-387.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Caballero Vázquez A,
    2. Garcia Flores P,
    3. Romero Ortiz A,
    4. García Del Moral R,
    5. Alcázar-Navarrete B.
    Small cell lung cancer: recent changes in clinical presentation and prognosis. Clin Respir J 2020; 14: 222-227.
    OpenUrl
  5. 5.
    1. Wang S,
    2. Zimmermann S,
    3. Parikh K,
    4. Mansfield AS,
    5. Adjei AA.
    Current diagnosis and management of small-cell lung cancer. Mayo Clin Proc 2019; 94: 1599-1622.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Wang Y,
    2. Zou S,
    3. Zhao Z,
    4. Liu P,
    5. Ke C,
    6. Xu S.
    New insights into small-cell lung cancer development and therapy. Cell Biol Int 2020; 44: 1564-1576.
    OpenUrl
  7. 7.↵
    1. Gazdar AF,
    2. Bunn PA,
    3. Minna JD.
    Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer 2017; 17: 725-737.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Liu C,
    2. Wang M,
    3. Zhang H,
    4. Li C,
    5. Zhang T,
    6. Liu H, et al.
    Tumor microenvironment and immunotherapy of oral cancer. Eur J Med Res 2022; 27: 198.
    OpenUrl
  9. 9.
    1. Mei Z,
    2. Huang J,
    3. Qiao B,
    4. Lam AK.
    Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma. Int J Oral Sci 2020; 12: 16.
    OpenUrlCrossRef
  10. 10.↵
    1. Mohan SP,
    2. Bhaskaran MK,
    3. George AL,
    4. Thirutheri A,
    5. Somasundaran M,
    6. Pavithran A.
    Immunotherapy in oral cancer. J Pharm Bioallied Sci 2019; 11: S107-S111.
    OpenUrl
  11. 11.↵
    1. Tiwari A,
    2. Trivedi R,
    3. Lin SY.
    Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci 2022; 29: 83.
    OpenUrl
  12. 12.↵
    1. Patel AP,
    2. Tirosh I,
    3. Trombetta JJ,
    4. Shalek AK,
    5. Gillespie SM,
    6. Wakimoto H, et al.
    Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014; 344: 1396-1401.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Tian Y,
    2. Li Q,
    3. Yang Z,
    4. Zhang S,
    5. Xu J,
    6. Wang Z, et al.
    Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer. Signal Transduct Target Ther 2022; 7: 346.
    OpenUrl
  14. 14.↵
    1. Regzedmaa O,
    2. Zhang H,
    3. Liu H,
    4. Chen J.
    Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges. Onco Targets Ther 2019; 12: 4605-4620.
    OpenUrlPubMed
  15. 15.↵
    1. Tran KA,
    2. Kondrashova O,
    3. Bradley A,
    4. Williams ED,
    5. Pearson JV,
    6. Waddell N.
    Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med 2021; 13: 152.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Li Y,
    2. Wu X,
    3. Yang P,
    4. Jiang G,
    5. Luo Y.
    Machine learning for lung cancer diagnosis, treatment, and prognosis. Genomics Proteomics Bioinformatics 2022; 20: 850-866.
    OpenUrl
  17. 17.↵
    1. Swanson K,
    2. Wu E,
    3. Zhang A,
    4. Alizadeh AA,
    5. Zou J.
    From patterns to patients: advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell 2023; 186: 1772-1791.
    OpenUrl
  18. 18.↵
    1. Hogeweg P.
    The roots of bioinformatics in theoretical biology. PLoS Comput Biol 2011; 7: e1002021.
    OpenUrlPubMed
  19. 19.↵
    1. Uesaka K,
    2. Oka H,
    3. Kato R,
    4. Kanie K,
    5. Kojima T,
    6. Tsugawa H, et al.
    Bioinformatics in bioscience and bioengineering: recent advances, applications, and perspectives. J Biosci Bioeng 2022; 134: 363-373.
    OpenUrl
  20. 20.↵
    1. Rudin CM,
    2. Brambilla E,
    3. Faivre-Finn C,
    4. Sage J.
    Small-cell lung cancer. Nat Rev Dis Primers 2021; 7: 3.
    OpenUrl
  21. 21.↵
    1. Wang WZ,
    2. Shulman A,
    3. Amann JM,
    4. Carbone DP,
    5. Tsichlis PN.
    Small cell lung cancer: subtypes and therapeutic implications. Semin Cancer Biol 2022; 86: 543-554.
    OpenUrl
  22. 22.↵
    1. Lahiri A,
    2. Maji A,
    3. Potdar PD,
    4. Singh N,
    5. Parikh P,
    6. Bisht B, et al.
    Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer 2023; 22: 40.
    OpenUrlCrossRef
  23. 23.
    1. Lazaroff J,
    2. Bolotin D.
    Targeted therapy and immunotherapy in melanoma. Dermatol Clin 2023; 41: 65-77.
    OpenUrl
  24. 24.↵
    1. Zhao W,
    2. Jin L,
    3. Chen P,
    4. Li D,
    5. Gao W,
    6. Dong G.
    Colorectal cancer immunotherapy-recent progress and future directions. Cancer Lett 2022; 545: 215816.
    OpenUrl
  25. 25.↵
    1. Sabari JK,
    2. Lok BH,
    3. Laird JH,
    4. Poirier JT,
    5. Rudin CM.
    Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol 2017; 14: 549-561.
    OpenUrlCrossRef
  26. 26.↵
    1. Helmink BA,
    2. Reddy SM,
    3. Gao J,
    4. Zhang S,
    5. Basar R,
    6. Thakur R, et al.
    B cells and tertiary lymphoid structures promote immunotherapy response. Nature 2020; 577: 549-555.
    OpenUrlCrossRefPubMed
  27. 27.
    1. Linde IL,
    2. Prestwood TR,
    3. Qiu J,
    4. Pilarowski G,
    5. Linde MH,
    6. Zhang X, et al.
    Neutrophil-activating therapy for the treatment of cancer. Cancer Cell 2023; 41: 356-372.
    OpenUrlCrossRef
  28. 28.↵
    1. Xiang X,
    2. Wang J,
    3. Lu D,
    4. Xu X.
    Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther 2021; 6: 75.
    OpenUrl
  29. 29.↵
    1. Ichimasa K,
    2. Kudo SE,
    3. Mori Y,
    4. Misawa M,
    5. Matsudaira S,
    6. Kouyama Y, et al.
    Correction: artificial intelligence may help in predicting the need for additional surgery after endoscopic resection of T1 colorectal cancer. Endoscopy 2018; 50: C2.
    OpenUrl
  30. 30.↵
    1. Huang JC,
    2. Tsai YC,
    3. Wu PY,
    4. Lien YH,
    5. Chien CY,
    6. Kuo CF, et al.
    Predictive modeling of blood pressure during hemodialysis: a comparison of linear model, random forest, support vector regression, XGBoost, LASSO regression and ensemble method. Comput Methods Programs Biomed 2020; 195: 105536.
    OpenUrl
  31. 31.↵
    1. Kang J,
    2. Choi YJ,
    3. Kim IK,
    4. Lee HS,
    5. Kim H,
    6. Baik SH, et al.
    LASSO-based machine learning algorithm for prediction of lymph node metastasis in T1 colorectal cancer. Cancer Res Treat 2021; 53: 773-783.
    OpenUrl
  32. 32.↵
    1. Reichling C,
    2. Taieb J,
    3. Derangere V,
    4. Klopfenstein Q,
    5. Le Malicot K,
    6. Gornet JM, et al.
    Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut 2020; 69: 681-690.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Zhao E,
    2. Xie H,
    3. Zhang Y.
    Predicting diagnostic gene biomarkers associated with immune infiltration in patients with acute myocardial infarction. Front Cardiovasc Med 2020; 7: 586871.
    OpenUrl
  34. 34.
    1. Chen D,
    2. Liu J,
    3. Zang L,
    4. Xiao T,
    5. Zhang X,
    6. Li Z, et al.
    Integrated machine learning and bioinformatic analyses constructed a novel stemness-related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients. Int J Biol Sci 2022; 18: 360-373.
    OpenUrl
  35. 35.↵
    1. Zhong Y,
    2. Zhang W,
    3. Hong X,
    4. Zeng Z,
    5. Chen Y,
    6. Liao S, et al.
    Screening biomarkers for systemic lupus erythematosus based on machine learning and exploring their expression correlations with the ratios of various immune cells. Front Immunol 2022; 13: 873787.
    OpenUrl
  36. 36.↵
    1. Newman AM,
    2. Liu CL,
    3. Green MR,
    4. Gentles AJ,
    5. Feng W,
    6. Xu Y, et al.
    Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 2015; 12: 453-457.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Hinshaw DC,
    2. Shevde LA.
    The tumor microenvironment innately modulates cancer progression. Cancer Res 2019; 79: 4557-4566.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Lei X,
    2. Lei Y,
    3. Li JK,
    4. Du WX,
    5. Li RG,
    6. Yang J, et al.
    Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett 2020; 470: 126-133.
    OpenUrl
  39. 39.↵
    1. Ling S,
    2. Hu Z,
    3. Yang Z,
    4. Yang F,
    5. Li Y,
    6. Lin P, et al.
    Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution. Proc Natl Acad Sci U S A 2015; 112: E6496-E6505.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Zhong R,
    2. Chen D,
    3. Cao S,
    4. Li J,
    5. Han B,
    6. Zhong H.
    Immune cell infiltration features and related marker genes in lung cancer based on single-cell RNA-seq. Clin Transl Oncol 2021; 23: 405-417.
    OpenUrl
  41. 41.↵
    1. Xie R,
    2. Liu L,
    3. Lu X,
    4. He C,
    5. Li G.
    Identification of the diagnostic genes and immune cell infiltration characteristics of gastric cancer using bioinformatics analysis and machine learning. Front Genet 2023; 13: 1067524.
    OpenUrl
  42. 42.↵
    1. Zhou G,
    2. Shen M,
    3. Zhang Z.
    ZW10 binding factor (ZWINT), a direct target of Mir-204, predicts poor survival and promotes proliferation in breast cancer. Med Sci Monit 2020; 26: e921659.
    OpenUrl
  43. 43.↵
    1. Peng F,
    2. Li Q,
    3. Niu SQ,
    4. Shen GP,
    5. Luo Y,
    6. Chen M, et al.
    ZWINT is the next potential target for lung cancer therapy. J Cancer Res Clin Oncol 2019; 145: 661-673.
    OpenUrlCrossRef
  44. 44.↵
    1. Wachowiak R,
    2. Mayer S,
    3. Suttkus A,
    4. Martynov I,
    5. Lacher M,
    6. Melling N, et al.
    CHL1 and NrCAM are primarily expressed in low grade pediatric neuroblastoma. Open Med (Wars) 2019; 14: 920-927.
    OpenUrl
  45. 45.↵
    1. Zhang Y,
    2. Sui F,
    3. Ma J,
    4. Ren X,
    5. Guan H,
    6. Yang Q, et al.
    Positive feedback loops between NrCAM and major signaling pathways contribute to thyroid tumorigenesis. J Clin Endocrinol Metab 2017; 102: 613-624.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords